IDEXX Laboratories (BSP:I1DX34) Cyclically Adjusted FCF per Share: R$8.05 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:I1DX34 IDEXX Laboratories Inc BSP:I1DX34
95 GF Score
Price R$578.89
GF Value R$657.69
Valuation Modestly Undervalued
View Full Analysis

What is IDEXX Laboratories Cyclically Adjusted FCF per Share?

IDEXX Laboratories BSP:I1DX34 95 Cyclically Adjusted FCF per Share is R$8.05 as of Jun. 2026. GuruFocus rates BSP:I1DX34 with a GF Score™ of 95/100 and a GF Value™ of R$657.69 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

IDEXX Laboratories's adjusted free cash flow per share for the three months ended in Jun. 2026 was R$4.143. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$8.05 for the trailing ten years ended in Jun. 2026.

During the past 12 months, IDEXX Laboratories's average Cyclically Adjusted FCF Growth Rate was 22.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 19.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 19.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of IDEXX Laboratories was 100.00% per year. The lowest was 11.90% per year. And the median was 19.90% per year.

As of today (2026-08-22), IDEXX Laboratories's current stock price is R$578.89. IDEXX Laboratories's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was R$8.05. IDEXX Laboratories's Cyclically Adjusted Price-to-FCF of today is 71.91.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of IDEXX Laboratories was 212.80. The lowest was 62.75. And the median was 105.32.


IDEXX Laboratories  (BSP:I1DX34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

IDEXX Laboratories's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=578.89/8.05
=71.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of IDEXX Laboratories was 212.80. The lowest was 62.75. And the median was 105.32.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


IDEXX Laboratories Cyclically Adjusted FCF per Share Related Terms


IDEXX Laboratories Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for IDEXX Laboratories's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDEXX Laboratories Cyclically Adjusted FCF per Share Chart

IDEXX Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.06 4.30 4.83 7.18 7.92

IDEXX Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.95 7.45 7.92 7.78 8.05

BSP:I1DX34 vs A, NTRA, WAT: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Cyclically Adjusted Price-to-FCF falls into.


BSP:I1DX34
95GF Score
IDEXX Laboratories Inc BSP:I1DX34
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDEXX Laboratories Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDEXX Laboratories's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.143/333.9520*333.9520
=4.143

Current CPI (Jun. 2026) = 333.9520.

IDEXX Laboratories Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.630 241.428 0.871
201612 0.636 241.432 0.880
201703 0.053 243.801 0.073
201706 0.699 244.955 0.953
201709 0.664 246.819 0.898
201712 0.733 246.524 0.993
201803 0.082 249.554 0.110
201806 0.776 251.989 1.028
201809 0.734 252.439 0.971
201812 0.847 251.233 1.126
201903 -0.034 254.202 -0.045
201906 0.909 256.143 1.185
201909 0.892 256.759 1.160
201912 1.030 256.974 1.339
202003 -0.246 258.115 -0.318
202006 2.205 257.797 2.856
202009 2.163 260.280 2.775
202012 2.422 260.474 3.105
202103 1.352 264.877 1.705
202106 2.453 271.696 3.015
202109 1.735 274.310 2.112
202112 2.339 278.802 2.802
202203 0.848 287.504 0.985
202206 0.425 296.311 0.479
202209 1.887 296.808 2.123
202212 1.554 296.797 1.749
202303 1.792 301.836 1.983
202306 1.998 305.109 2.187
202309 2.803 307.789 3.041
202312 2.537 306.746 2.762
202403 1.997 312.332 2.135
202406 2.777 314.175 2.952
202409 2.560 315.301 2.711
202412 3.293 315.605 3.484
202503 2.923 319.799 3.052
202506 2.077 322.561 2.150
202509 4.758 324.800 4.892
202512 4.422 324.054 4.557
202603 3.033 330.213 3.067
202606 4.143 333.952 4.143

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of R$8.05 mean?
IDEXX Laboratories (BSP:I1DX34) has a Cyclically Adjusted FCF per Share of R$8.05 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on IDEXX Laboratories and its competitors.
Is IDEXX Laboratories' Cyclically Adjusted FCF per Share too high?
IDEXX Laboratories' current Cyclically Adjusted FCF per Share is R$8.05. Overall, IDEXX Laboratories has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IDEXX Laboratories' Cyclically Adjusted FCF per Share compare to A and NTRA?
IDEXX Laboratories' Cyclically Adjusted FCF per Share of R$8.05 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on IDEXX Laboratories and its competitors. IDEXX Laboratories's current Cyclically Adjusted FCF per Share is R$8.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEXX Laboratories stock overvalued right now?
Based on GuruFocus' analysis, IDEXX Laboratories (BSP:I1DX34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$657.69, compared to a current price of R$578.89 — trading 12% below its estimated fair value. The current Cyclically Adjusted FCF per Share is R$8.05. IDEXX Laboratories' overall GF Score™ is 95/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For IDEXX Laboratories (BSP:I1DX34), the current Cyclically Adjusted FCF per Share is R$8.05 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDEXX Laboratories (BSP:I1DX34) Overvalued in 2026?

Based on GuruFocus' analysis, IDEXX Laboratories stock appears to be undervalued. The current stock price of R$578.89 is trading 12% below its estimated GF Value™ of R$657.69. GuruFocus considers IDEXX Laboratories to be Modestly Undervalued.

Key valuation signals for BSP:I1DX34:

  • Cyclically Adjusted FCF per Share: R$8.05
  • GF Value™: R$657.69 vs. price of R$578.89 (12% below fair value)
  • GF Score™: 95/100

No single metric tells the full story. See the BSP:I1DX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDEXX Laboratories Business Description

Address One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
95GF Score

Get the complete analysis for BSP:I1DX34

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$578.89
Price
R$657.69
GF Value